Related Experiment Videos
A persistent contradiction in treatment providers' views on addiction
1School of Medicine, University of California, San Francisco, USA.
Drug and Alcohol Review
|April 18, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis.
SSM. Qualitative research in health·2026
Tobacco Industry Contributions to the Development of Ultraprocessed Food in the United States, 1985-2007: A Case Study of Lunchables.
American journal of public health·2026
Pouring Rights Contracts Between Soda Companies and Public Universities: An Institutional Barrier to Sugar-Sweetened Beverage Reduction.
International journal of health policy and management·2026
Enacting healthy checkout policies: lessons from Berkeley and Perris, California.
Public health nutrition·2025
People Seeking Treatment for Meth/Amphetamine Use Are Getting Older and Treatment Services Need to Adapt.
Drug and alcohol review·2026
Analysis of Methamphetamine-Related Deaths: A Retrospective Cross-Sectional Study.
Drug and alcohol review·2026
Experiences of Healthcare Support and Access Among Women Who Use Performance and Image-Enhancing Drugs.
Drug and alcohol review·2026
Effectiveness without safety: a response to Duggan, Hardy, and Waller (2026).
Journal of eating disorders·2026
Digital Cognitive Behavioral Therapy Reduces Heavy Drinking Among a Non-Treatment Sample of People With Alcohol Use Disorder: A Feasibility Trial With CBT4CBT.
Alcohol, clinical & experimental research·2026
A Diagnosis of Exclusion - Adult-Onset Still's Disease: A Case Report.
South Dakota medicine : the journal of the South Dakota State Medical Association·2026
OUTPACE Tobacco study protocol: a tobacco-free workplace program for dissemination and implementation in opioid use treatment programs in Texas.
Addiction science & clinical practice·2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.
The British journal of psychiatry : the journal of mental science·2026
When "Kava" Isn't Kava: Opioid-like Withdrawal Responsive to Buprenorphine: A Case Study.
Journal of addiction medicine·2026